Ironwood Pharmaceuticals, Inc. (IRWD)

NASDAQ: IRWD · Real-Time Price · USD

3.370

-0.010 (-0.30%)

At close: Mar 13, 2026, 4:00 PM EDT

3.470

+0.100 (2.97%)

After-hours: Mar 13, 2026, 7:51 PM EDT

Ironwood Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	296.15	351.41	442.74	410.6	413.75
Revenue Growth (YoY)	-15.72%	-20.63%	7.83%	-0.76%	6.22%
Selling, General & Admin	82.26	144.27	158.31	115.99	111.13
Research & Development	95.14	111.42	116.09	44.27	70.41
Other Operating Expenses	20.26	2.59	1,114	-	-0.04
Total Operating Expenses	197.65	258.29	1,388	160.26	181.49
Operating Income	98.5	93.12	-945.43	250.34	232.26
Interest Income	4.08	4.47	18.97	9.5	0.73
Interest Expense	-32.75	-33.03	-21.63	-7.6	-31.15
Other Non-Operating Income (Expense)	-28.28	-27.29	-2.62	2.27	-32.78
Total Non-Operating Income (Expense)	-56.95	-55.85	-5.28	4.17	-63.2
Pretax Income	70.03	65.2	-948.07	252.42	200.66
Provision for Income Taxes	-46.01	-64.32	-83.49	-77.36	327.79
Net Income	24.02	0.88	-2,034	350.13	1,057
Minority Interest in Earnings	-	-	-29.32	-	-
Net Income to Common	24.02	0.88	-2,034	350.13	1,057
Net Income Growth	2629.20%	-	-	-66.87%	895.42%
Shares Outstanding (Basic)	162	159	155	154	162
Shares Outstanding (Diluted)	163	160	155	186	164
Shares Change (YoY)	1.81%	2.99%	-16.57%	13.32%	2.34%
EPS (Basic)	0.15	0.01	-6.45	1.13	3.26
EPS (Diluted)	0.15	0.01	-6.45	0.96	3.21
EPS Growth	1400.00%	-	-	-70.09%	386.36%
Free Cash Flow	127.01	103.41	183.15	273.63	261.63
Free Cash Flow Growth	22.82%	-43.54%	-33.06%	4.58%	56.67%
Free Cash Flow Per Share	0.78	0.65	1.18	1.47	1.59
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	33.26%	26.50%	-213.54%	60.97%	56.13%
Profit Margin	39.18%	36.86%	-195.28%	80.32%	-30.73%
FCF Margin	42.89%	29.43%	41.37%	66.64%	63.23%
EBITDA	100.38	95.14	-943.86	251.76	233.78
EBITDA Margin	33.90%	27.07%	-213.19%	61.31%	56.50%
EBIT	98.5	93.12	-945.43	250.34	232.26
EBIT Margin	33.26%	26.50%	-213.54%	60.97%	56.13%
Effective Tax Rate	-65.70%	-98.65%	8.81%	-30.65%	163.36%

Updated Feb 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q